Therapeutic Targeting of ATP7B in Ovarian Carcinoma.

Mangala LS, Zuzel V, Schmandt R, Leshane ES, Halder JB, Armaiz-Pena GN, Spannuth WA, Tanaka T, Shahzad MM, Lin YG, Nick AM, Danes CG, Lee JW, Jennings NB, Vivas-Mejia PE, Wolf JK, Coleman RL, Siddik ZH, Lopez-Berestein G, Lutsenko S, Sood AK. Therapeutic Targeting of ATP7B in Ovarian Carcinoma. Clin Cancer Res. 2009 Jun 01; 15(11):3770-80.

View in: PubMed

subject areas

Adenosine Triphosphatases
Animals
Antineoplastic Agents
Apoptosis
Binding Sites
Blotting, Western
Cation Transport Proteins
Cell Line, Tumor
Cell Proliferation
Cell Survival
Cisplatin
DNA Adducts
Drug Resistance, Neoplasm
Female
Humans
Immunohistochemistry
Mice
Mice, Nude
Ovarian Neoplasms
Protein Binding
Reverse Transcriptase Polymerase Chain Reaction
RNA Interference
Tumor Burden
Xenograft Model Antitumor Assays

authors with profiles

Pablo Vivas
Guillermo N Armaiz Pena

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support